Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Pharmaceutical Research

Volumn 16, Issue 8, 1999, Pages 1294-1299

  Péan, Jean Manuel ^a   Boury, Franck ^a   Venier Julienne, Marie Claire ^a   Menei, Philippe ^b   Proust, Jacques Emile ^a   Benoit, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Interfacial tension; Microencapsulation; NGF; PEG; PLGA; Protein stability

Indexed keywords

MACROGOL 400; MICROSPHERE; NERVE GROWTH FACTOR;

AQUEOUS SOLUTION; ARTICLE; DRUG ADSORPTION; DRUG DEGRADATION; DRUG PENETRATION; DRUG STABILITY; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; MICROENCAPSULATION; PRIORITY JOURNAL; PROTEIN STABILITY; SURFACE TENSION; SUSTAINED DRUG RELEASE;

BIODEGRADATION, ENVIRONMENTAL; CAPSULES; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; LACTIC ACID; MICROSPHERES; NERVE GROWTH FACTOR; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS;

EID: 0032863592     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014818118224     Document Type: Article

References (22)

1. 1. P. J. Camarata, R. Suryanarayanan, D. A. Turner, R. G. Parker, and T. J. Ebner. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30:313-319 (1992).
2. 2. S. Mittal, A. Cohen, and D. Maysinger. In vitro effects of brain derived neurotrophic factor released from microspheres. Neuroreport 5:2577-2582 (1994)
3. 3. C. E. Krewson, R. Dause, M. Mak, and W. M. Saltzman. Stabilization of nerve growth factor in controlled release polymers and tissue. J. Biomater. Sci. Polym. Ed. 8:103-117 (1996).
4. 4. D. Maysinger, K. Krieglstein, J. Filipovic-Grcic, M. Sendtner, K. Unsicker, and P. Richardson. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities. Exp. Neurol. 138:177-188 (1996).
5. 5. J. M. Péan, M. C. Venier-Julienne, R. Filmon, M. Sergent, R. Phan-Tan-Luu, and J. P. Benoit. Optimization of HSA and NGF encapsulation yields in PLGA microparticles. Int. J. Pharm. 166:105-115 (1998).
6. 6. J. M. Péan, M. C. Venier-Julienne, F. Boury, P. Menei, B. Denizot, and J. P. Benoit. NGF release from poly(d,l-laclide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J. Contr. Rel. 56:175-187 (1998).
7. 7. J. Herrmann and R. Bodmeier. The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Contr. Rel. 36:63-71 (1995).
8. 8. T. Uchida, K. Yoshida, A. Ninomiya, and S. Goto. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. Chem. Pharm. Bull. 43:1569-1573 (1995).
9. 9. J. L. Cleland and A. J. S. Jones. Stable formulations of recombinant human growth hormone and interferon-gamma for microencupsulation in biodegradable microspheres. Pharm. Res. 13:1464-1475 (1996).
10. 10. L. Chen, R. N. Apte, and S. Cohen. Characterization of PLGA microspheres for the controlled delivery of IL-Iα for tumor immunotherapy. J. Contr. Rel. 43:261-272 (1997).
11. 11. P. Johansen, Y. Men, R. Audran, G. Corradin, H. P. Merkle, and B. Gander. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm. Res. 15:1103-1110 (1998).
12. 12. J. Nanduri, S. M. Vroegop, S. E. Buxser, and K. E. Neet. Immunological determinants of nerve growth factor involved in p140 trk (Trk) receptor binding. J. Neurosci. Res. 37:433-444 (1994).
13. 13. F. Boury, T. Ivanova, I. Panaïotov, J. E. Proust, A. Bois, and J. Richou. Dilatational properties of adsorbed poly(D,L-lactide) and bovine serum albumin monolayers at the dichloromethane/water interface. Langmuir 11:1636-1644 (1995).
14. 14. J. E. Proust, F. Boury, P. Saulnier, J. P. Benoit, I. Panaïotov, and T. Ivanova. Structure, morphology and degradation of poly(α-hydroxy acid)s microspheres in relation with monolayers. Curr. Top. Coll. Int. Sci. 1:195-224 (1997).
15. 15. F. Boury, H. Marchais, J. E. Proust, and J. P. Benoit. Bovine serum albumin release from poly(α-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties. J. Contr. Rel. 45:75-86 (1997).
16. 16. T. Verrecchia, P. Huve, D. Bazile, M. Veillard, G. Spenlehauer, and P. Couvreur. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J. Biomed. Mater. Res. 27:1019-1028 (1993).
17. 17. R. R. Almon and S. Varon. Associations of beta nerve growth factor with bovine serum albumin as well as with the alpha and gamma subunits of the 7S macromolecule. J. Neuroch. 30:1559-1567 (1978).
18. 18. T. Arakawa and S. N. Timasheff. Mechanism of poly(ethylene glycol) interaction with proteins. Biochemistry 24:6756-6762 (1985).
19. 19. K. Lim and J. N. Herron. Molecular simulation of protein-PEG interaction. In J. M. Harris (eds), Poly(ethylene glycol) chemistry, biotechnical and biomedical application, Plenum Press, New York, 1992, pp. 29-55.
20. 20. J. M. Harris. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In J. M. Harris (eds), Poly(ethylene glycol) chemistry, biotechnical and biomedical application, Plenum Press, New York, 1992, pp. 1-12
21. 21. M. Katakam, L. N. Bell, and A. K. Banga. Effect of surfactants on the physical stability of recombinant human growth hormone. J. Pharm. Sci. 84:713-716 (1995).
22. 22. T. G. Park, W. Lu, and G. Crotts. Importance of the in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Contr. Rel. 33:211-222 (1995).